小RNA
癌症研究
乳腺癌
癌变
癌细胞
核糖核酸
下调和上调
转移
体外
三阴性乳腺癌
癌症
RNA干扰
表皮生长因子受体
化学
生物
医学
基因
内科学
生物化学
作者
Tinghong Zhang,Yun‐Long Wu,Dejun Yang,Cunzao Wu,Huaqiong Li
标识
DOI:10.1016/j.bbrc.2021.04.040
摘要
MicroRNAs play an irreplaceable role in gene expression regulation. Upregulation of several miRNAs increases the risk of invasion and metastasis of breast cancer cells. An oncogenic miRNA, miR-21, is highly expressed in triple-negative breast cancer (TNBC) and is associated with tumor proliferation, invasion, carcinogenesis, prognosis, and therapeutic resistance. However, targeted delivery of therapeutic anti-miRNAs into cancer cells remains challenging, especially for TNBC. In this study, we report the application of an RNA nanotechnology-based platform for the targeted delivery of anti-miR-21 by epidermal growth factor receptor (EGFR) aptamer in vitro to TNBC and chemical-resistant breast cancer cells. RNA nanoparticles reduced cell viability and sensitized breast cancer cells to doxorubicin (DOX) treatment in vitro. Inhibition of miR-21 by RNA nanoparticles suppressed TNBC cell invasion, migration, and colony formation. The results indicate the potential application of nanotechnology-based delivery platforms in clinical anti-cancer therapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI